Search

Fine Co(OH)2 powder was prepared by simple precipitation from aqueous solutions of cobalt sulfate and sodium hydroxide without using sophisticated reagents and/or approaches. The fine powder was homogeneously mixed with protonated betaine bis((trifluoromethyl)sulfonyl)amide ionic liquid ([Hbet][TFSA] IL), an amide-type hydrophobic protic IL, and then dispersed in ethanol with graphene nanopowder for being spin-coated upon screen-printed carbon electrode (SPCE) to prepare the glucose-reactive electrode. Activation of the electrode was essential to expose the glucose-oxidation activity, and the experimental evidences indicated that Co3O4 converted from Co(OH)2 during the activation process was the active species in charge of glucose oxidation. The electrode showed a wide linear dynamic range for glucose from 1 to 1757 µM with a high sensitivity of 632 µA cm− 2 mM− 1 and a detection limit of 1 µM in the electrolyte containing 0.5 M NaOH and 0.1 M NaCl. The electrode showed no response to common interferants, including alcohols, in the concentration the same as to glucose. However, ascorbic acid in the same concentration level showed severe interference but negligible in the physiological level. This study shows that Co(OH)2 prepared by facile precipitation is qualified of being an efficient electrocatalyst precursor for glucose oxidation, and IL is a good binder for immobilizing the electrocatalyst. [ABSTRACT FROM AUTHOR]

Objective. To investigate the expression patterns and prognostic values of STEAP family members in the occurrence and development of breast cancer. Materials and Methods. The Human Protein Atlas was used to analyze the expression level of STEAPs in human normal tissues and malignant tumors. ONCOMINE datasets were analyzed for the comparison of the STEAPs levels between malignant cancers and corresponding normal tissues. Kaplan-Meier plotter was used to analyze the prognostic value of STEAPs in breast cancer patients. Results. STEAPs were widely distributed in human normal tissues with diverse levels. Normally, it is predicted that STEAP1 and STEAP2 were involved in the mineral absorption process, while STEAP3 participated in the TP53 signaling pathway and iron apoptosis. The results from ONCOMINE showed downregulation of STEAP1, STEAP2, and STEAP4 in breast cancers. Survival analysis revealed that breast cancer patients with high levels of STEAP1, STEAP2, and STEAP4 had a good prognosis, while those with low expression had high overall mortality. Conclusion. STEAP1, STEAP2, and STEAP4 are predicted to be the potential prognostic biomarkers for breast cancer patients, providing novel therapeutic strategies for them. [ABSTRACT FROM AUTHOR]